Back to Browse Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 5

Interleukin-6 and airflow limitation in chemical warfare patients with chronic obstructive pulmonary disease

Authors Davood Attaran, Shahrzad M Lari, Mohammad Towhidi, et al

Published 30 September 2010 Volume 2010:5 Pages 335—340


Review by Single-blind

Peer reviewer comments 3

Davood Attaran1, Shahrzad M Lari1, Mohammad Towhidi1, Hassan Ghobadi Marallu2, Hossein Ayatollahi1, Mohammad Khajehdaluee1, Mostafa Ghanei3, Reza Basiri1
1Lung Disease and Tuberculosis Research Center, Mashhad University of Medical Science, 2Ardabil University of Medical Sciences, 3Research Center of Chemical Injuries, Baqiyatallah University of Medical Sciences, Tehran, Iran

Objectives: Chronic obstructive pulmonary disease (COPD) is one of the main late complications of sulfur mustard poisoning. The aim of this study was to evaluate serum levels of interleukin (IL)-6 in war veterans with pulmonary complications of sulfur mustard poisoning and their correlation with severity of airways disease.
Methods: Fifty consecutive patients with sulfur mustard poisoning and stable COPD, and of mean age 46.3 ± 9.18 years were enrolled in this study. Thirty healthy men were selected as controls and matched to cases by age and body mass index. Spirometry, arterial blood gas, six-minute walk test, BODE (body mass index, obstruction, dyspnea, and exercise capacity), and St George’s Respiratory Questionnaire about quality of life were evaluated. Serum IL-6 was measured in both patient and control groups.
Results: Fifty-four percent of patients had moderate COPD. Mean serum IL-6 levels were 15.01 ± standard deviation (SD) 0.61 pg/dL and 4.59 ± 3.40 pg/dL in the case and control groups, respectively (P = 0.03). There was a significant correlation between IL-6 levels and Global Initiative for Chronic Obstructive Lung Disease stage (r = 0.25, P = 0.04) and between IL-6 and BODE index (r = 0.38, P = 0.01). There was also a significant negative correlation between serum IL-6 and forced expiratory volume in one second (FEV1, r = -0.36, P = 0.016).
Conclusion: Our findings suggest that serum IL-6 is increased in patients with sulfur mustard poisoning and COPD, and may have a direct association with airflow limitation.

Keywords: sulfur mustard, chronic obstructive pulmonary disease, interleukin-6, inflammation, chemical warfare

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] View Full Text [HTML] 


Readers of this article also read:

miR-98 targets ITGB3 to inhibit proliferation, migration, and invasion of non-small-cell lung cancer

Ni R, Huang Y, Wang J

OncoTargets and Therapy 2015, 8:2689-2697

Published Date: 22 September 2015

Nivolumab in the treatment of malignant melanoma: review of the literature

Mashima E, Inoue A, Sakuragi Y, Yamaguchi T, Sasaki N, Hara Y, Omoto D, Ohmori S, Haruyama S, Sawada Y, Yoshioka M, Nishio D, Nakamura M

OncoTargets and Therapy 2015, 8:2045-2051

Published Date: 6 August 2015

Ultrasmall cationic superparamagnetic iron oxide nanoparticles as nontoxic and efficient MRI contrast agent and magnetic-targeting tool

Uchiyama MK, Toma SH, Rodrigues SF, Shimada AL, Loiola RA, Cervantes Rodríguez HJ, Oliveira PV, Luz MS, Rabbani SR, Toma HE, Poliselli Farsky SH, Araki K

International Journal of Nanomedicine 2015, 10:4731-4746

Published Date: 28 July 2015

Magnetic resonance-guided regional gene delivery strategy using a tumor stroma-permeable nanocarrier for pancreatic cancer

Wang Q, Li J, An S, Chen Y, Jiang C, Wang X

International Journal of Nanomedicine 2015, 10:4479-4490

Published Date: 13 July 2015

Detection of epidermal growth factor receptor mutation in lung cancer by droplet digital polymerase chain reaction

Xu Q, Zhu Y, Bai Y, Wei X, Zheng X, Mao M, Zheng G

OncoTargets and Therapy 2015, 8:1533-1541

Published Date: 22 June 2015

Electrospun fibrous scaffolds combined with nanoscale hydroxyapatite induce osteogenic differentiation of human periodontal ligament cells

Wu XN, Miao LY, Yao YF, Wu WL, Liu Y, Chen XF, Sun WB

International Journal of Nanomedicine 2014, 9:4135-4143

Published Date: 27 August 2014

Effect of dispersants of multi-walled carbon nanotubes on cellular uptake and biological responses

Haniu H, Saito N, Matsuda Y, Kim YA, Park KC, Tsukahara T, Usui Y, Aoki K, Shimizu M, Ogihara N, Hara K, Takanashi S, Okamoto M, Ishigaki N, Nakamura K, Kato H

International Journal of Nanomedicine 2011, 6:3295-3307

Published Date: 9 December 2011

The pathophysiology of bronchiectasis

Paul T King

International Journal of Chronic Obstructive Pulmonary Disease 2009, 4:411-419

Published Date: 30 October 2009

Long-term therapy in COPD: any evidence of adverse effect on bone?

Arnulf Langhammer, Siri Forsmo, Unni Syversen

International Journal of Chronic Obstructive Pulmonary Disease 2009, 4:365-380

Published Date: 30 September 2009

Life expectancy and years of life lost in chronic obstructive pulmonary disease: Findings from the NHANES III Follow-up Study

Robert M Shavelle, David R Paculdo, Scott J Kush, David M Mannino, David J Strauss

International Journal of Chronic Obstructive Pulmonary Disease 2009, 4:137-148

Published Date: 18 March 2009